Premium
Signaling and ligand interaction of ILT7: receptor‐mediated regulatory mechanisms for plasmacytoid dendritic cells
Author(s) -
Cao Wei,
Bover Laura
Publication year - 2010
Publication title -
immunological reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.839
H-Index - 223
eISSN - 1600-065X
pISSN - 0105-2896
DOI - 10.1111/j.0105-2896.2009.00867.x
Subject(s) - biology , microbiology and biotechnology , ligand (biochemistry) , receptor , signal transduction , immunology , genetics
Summary: Plasmacytoid dendritic cells (pDCs) are specialized dendritic cells (DCs) that produce large amounts of type I interferon (IFN) after Toll‐like receptor (TLR) activation. Human pDCs preferentially express immunoglobulin‐like transcript 7 (ILT7; LILRA4), which couples with a signaling adapter to activate a prominent immunoreceptor tyrosine‐based activation motif (ITAM)‐mediated signaling pathway. ILT7 protein directly binds to and can be activated by bone marrow stromal cell antigen 2 (BST2; CD317) protein, the expression of which is found on cells pre‐exposed to IFN or on the surface of human cancer cells. The interaction between ILT7 and BST2 functions to assure an appropriate TLR response by pDCs during viral infection and likely participates in pDC‐tumor crosstalk. Two opposing modes of receptor‐mediated regulatory mechanisms work jointly to fine tune the innate immunity of pDCs.